The Positive Inotropic Effect of Relaxin-2 in Human Atrial Myocardium is Preserved in End-Stage Heart Failure: Role of Gi-Phosphoinositide-3 Kinase Signaling

2011 ◽  
Vol 17 (2) ◽  
pp. 158-166 ◽  
Author(s):  
Thomas Dschietzig ◽  
Konstantin Alexiou ◽  
Hans-Tilman Kinkel ◽  
Gert Baumann ◽  
Klaus Matschke ◽  
...  
2010 ◽  
Vol 16 (12) ◽  
pp. 931-937 ◽  
Author(s):  
Sanjoy Bhattacharya ◽  
Kaleab Abebe ◽  
Marc Simon ◽  
Samir Saba ◽  
Evan Adelstein

2015 ◽  
Vol 9s2 ◽  
pp. CMC.S19694 ◽  
Author(s):  
Allison McLarty

Heart failure is epidemic in the United States with a prevalence of over 5 million. The diagnosis carries a mortality risk of 50% at 5 years rivaling many diagnoses of cancer. Heart transplantation, long the “gold standard” treatment for end stage heart failure unresponsive to maximal medical therapy falls way short of meeting the need with only about 2,000 transplants performed annually in the United States due to donor limitation. Left ventricular devices have emerged as a viable option for patients as both a “bridge to transplantation” and as a final “destination therapy”.


2019 ◽  
pp. 331-340
Author(s):  
Lech Paluszkiewicz ◽  
Tomasz Kukulski ◽  
Michał Zembala ◽  
Jan Gummert ◽  
Michiel Morshuis

2012 ◽  
Vol 157 (3) ◽  
pp. 432-433 ◽  
Author(s):  
Zhiqiang Zhao ◽  
Tong Liu ◽  
Guangping Li

Sign in / Sign up

Export Citation Format

Share Document